Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.

Published in:

Health Technology Assessment, 2021, v. 25, n. 75, p. vii, doi. 10.3310/hta25750

By:

• Marson, Anthony G.;
• Burnside, Girvan;
• Appleton, Richard;
• Smith, Dave;
• Leach, John Paul;
• Sills, Graeme;
• Tudur-Smith, Catrin;
• Plumpton, Catrin O.;
• Hughes, Dyfrig A.;
• Williamson, Paula R.;
• Baker, Gus;
• Balabanova, Silviya;
• Taylor, Claire;
• Brown, Richard;
• Hindley, Dan;
• Howell, Stephen;
• Maguire, Melissa;
• Mohanraj, Rajiv;
• Smith, Philip E. M.

Publication type:

Article